MAPT and Alzheimer disease: Indeed, the only AD mouse model characterized by tau pathology is a triple transgenic mouse expressing specifically in the MAPT gene the P301L mutation, which, in patients, relates to familial frontotemporal dementia (3xTg-AD mouse)10,11.